IL6 and myocarditis: NLRP3 activation leads to the release of interleukin-1β (IL-1β), tumor necrosis factor-alpha (TNF-α), and interleukin-6 (IL-6), cytokines that are directly implicated in the pathogenesis of myocarditis and other cardiovascular inflammatory disorders [18,19].